SPONSORED CONTENT
TIP: Maximize 340B savings by manually pulling in rejected and qualified claims.
Manually pulling in rejected and
Category: Sponsored Content
SPONSORED CONTENT
Whether it’s new manufacturer restrictions affecting script and data qualification, amended state laws or regulations, or updated audit guidelines, the 340B landscape is constantly evolving. So, it’s no surprise that managing an organization’s 340B program is not easy
…
Q: Where did you grow up?
I grew up in the suburbs of Atlanta.
Q: Where did you go to college?
I received my Bachelor of Science in Biomedical Sciences from Auburn University.
Q: What are your favorites?
Food: Probably ice cream!
Movie: Avengers: Endgame
Musicians: I love most music- anything from country to
…SPONSORED CONTENT
The U.S. drug pricing infrastructure is entering a transformative era. On August 1, 2025, the Health Resources and Services Administration (HRSA) announced a voluntary 340B Rebate Model Pilot, aligned with the Inflation Reduction Act’s Maximum Fair Price (MFP) provisions
…SPONSORED CONTENT
The 340B program has morphed into a battlefield of rules, audits, and reporting. For smaller covered entities (CEs), especially rural hospitals and community clinics, keeping pace feels like a losing race. While large health systems deploy entire
…
Q: Tell us some interesting details about your company’s history.
Plenful was founded with a clear mission: to transform healthcare operations from the inside out. Our Founder
…
SPONSORED CONTENT
TIP: When a covered entity participates with 340B ESP™ to obtain 340B pricing restoration, it is critical to monitor manufacturer policies, ESP eligibility,
SPONSORED CONTENT
Since this article was published, HRSA released new guidance on a proposed pilot rebate model. This pilot would permit manufacturers to offer 340B rebates for a limited set of drugs under defined conditions. Read more in 340B
…SPONSORED CONTENT
The regulatory landscape for the 340B drug pricing program is evolving rapidly. As scrutiny from the Health Resources and Services Administration (HRSA) and drug manufacturers intensifies, healthcare leaders and 340B teams face growing pressure to maintain airtight
…SPONSORED CONTENT
AI is everywhere—chatbots, smart assistants, predictive tools. But in 340B? The line between what’s useful and what’s just marketing is getting blurrier by the day.
We’ve seen AI do
…